Transient myeloproliferative disorder in a neonate without Down syndrome;Syndrome myélo-prolifératif transitoire chez un nouveau-né indemne de toute pathologie constitutionnelle

Annales de Biologie Clinique

Volumn 65, Issue 5, 2007, Pages 569-573

  Adam, M ^a   Vincenot, A ^b   Gouraud, F ^b   Harvel, C ^b   Perot, C ^c   Portnoi, M F ^c   Andre Kerneis, E ^b   Giraudier, S ^d   Leverger, G ^a   Favier, R ^a  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b CENTRE HOSPITALIER DE MEAUX   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d HENRI MONDOR HOSPITAL   (France)

Author keywords

Down syndrome; GATA1; Transient leukemia; Transient myeloproliferative disorder

Indexed keywords

GATA1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

ARTICLE; CASE REPORT; DIZYGOTIC TWINS; DOWN SYNDROME; EXON; FOLLOW UP; GENE DELETION; GENETICS; HUMAN; MALE; MUTATION; MYELOPROLIFERATIVE DISORDER; NEWBORN; PREMATURITY; REMISSION; TWINS;

DISEASES IN TWINS; DOWN SYNDROME; EXONS; FOLLOW-UP STUDIES; GATA1 TRANSCRIPTION FACTOR; GENE DELETION; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; MUTATION; MYELOPROLIFERATIVE DISORDERS; REMISSION, SPONTANEOUS; TWINS, DIZYGOTIC;

EID: 35349004269     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: 10.1684/abc.2007.0158     Document Type: Article

References (13)

1. Karandikar NJ, Aquino DB, Mc Kenna RW, Kroft SH. Transient myeloproliferative disorder and acute myeloid leukaemia in Down syndrome; an immunophenotypic analysis. Am J Clin Pathol 2001 ; 116 : 204-10.
2. Polski JM, Galambos C, Gale GB, Dunphy CH, Evans HL, Batanian JR. Acute megakaryoblastic leukaemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate. Am J Pediatr Hematol Oncol 2002 ; 24 : 50-4.
3. Cushing T, Clericuczio CL, Wilson CS, et al. Risk for leukaemia in infants without Down syndrome who have transient myeloproliferative disorder. J Pediatr 2006 ; 148 : 687-9.
4. Kounami S, Aoyagi N, Tsuno H, Suzuki H, Kitano N, Koike M. Additionalchromosome abnormalities in transient abnormal myelopoiesis in Down's syndrome patients. Acta Haematol 1997 ; 98 : 109-12.
5. Vyas P, Ault K, Jackson CW, Orkin SH, Shivdanasi A. Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood 1999 ; 93 : 2867-75.
6. Wechsler J, Greene M, McDevitt MA, et al. Acquired mutations in GATA-1 in the megakaryoblastic leukaemia of Down syndrome. Nat Genet 2002 ; 32 : 148-52.
7. Ahmed M, Sternberg A, Hall G, et al. Natural history of GATA-1 mutations in Down syndrome. Blood 2004 ; 103 : 2480-9.
8. Xu G, Nagano M, Kanezaki R, et al. Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome. Blood 2003 ; 102 : 2960-8.
9. Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH. Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1. Nat Genet 2005 ; 37 : 613-8.
10. Massey GV, Zipursky A, Chang MN, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. Blood 2006 ; 107 : 4606-13.
11. Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A. GATA-1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 2003 ; 101 : 4301-4.
12. Stark B, Jeison M, Preudhomme C, et al. Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukaemia in young monozygotic twins. Br J Hematol 2002 ; 118 : 1082-6.
13. Shimada A, Xu G, Toki T, Kimura H, Hayashi Y, Ito E. Fetal origin of the GATA1 mutation in identical twins with transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome. Blood 2004 ; 103 : 366.